Organisation › Details
4-Antibody AG, Jena
4-Antibody is a biopharmaceutical company with a powerful fully-human antibody drug-discovery technology platform which is generating an emerging pipeline of antibody therapeutics. The proprietary discovery engine is the in vitro Retrocyte Display® technology, a fast and highly efficient source of antibody drug candidates. Retrocyte Display® generates high quality therapeutic antibody drug candidates quickly using a rapid, high-throughput, flow cytometry approach incorporating fulllength IgG format human antibody libraries expressed in mammalian B cells. 4-Antibody provides access to its technologies to select pharmaceutical R&D collaborators and is also generating an inhouse pipeline of antibody drugs. The Company's lead development product is an anticytomegalovirus antibody drug. 4-Antibody is a private company with strong, commerciallyexperienced leadership located in Basel, Switzerland and Jena, Germany. *
|Street||2 Winzerlaer Str.|
|Address record changed: 2014-04-28|
|Basic data||Employees||B: 11 to 50 (2008-10-01)|
|* Document for »About Section«: 4-Antibody AG. (8/16/11). "Press Release: 4-Antibody AG Forms Collaboration with Human Genome Sciences". Basel.|
Record changed: 2014-09-05
More documents for Agenus (Group)
-  Agenus Inc.. (5/8/14). "Press Release: Agenus Reports First Quarter 2014 Financial Results". Lexington, MA....
-  Agenus Inc.. (4/28/14). "Press Release: Agenus Announces Collaboration and License Agreement with Merck for Novel Checkpoint Antibody-based Cancer Immunotherapies". Lexington, MA....
-  Agenus Inc.. (3/5/14). "Press Release: Agenus Reports Fourth Quarter and Full Year 2013 Financial Results". Lexington, MA....
-  Agenus Inc.. (2/13/14). "Press Release: Agenus Closes Acquisition of 4-Antibody". Lexington, MA....
-  Agenus Inc.. (2/10/14). "Press Release: Agenus Announces Closing of Public Offering and Exercise of Over-allotment Option". Lexington, MA....
-  Agenus Inc.. (1/13/14). "Press Release: Agenus Enters into Definitive Agreement to Acquire Privately Held 4-Antibody AG". Lexington, MA....
-  4-Antibody AG. (1/29/13). "Press Release: 4-Antibody AG and the Ludwig Institute Expand Oncology Antibody R&D Program with Three New Targets". Basel & New York, NY....
-  4-Antibody AG. (10/8/12). "Press Release: 4-Antibody AG Receives Additional Milestone Payments from Human Genome Sciences". Basel....
-  Evotec AG. (5/9/12). "Press Release: Evotec AG and 4-Antibody AG Form Strategic Collaboration to Innovate Antibody Selection. Evotec and 4-Antibody Launch New High Content Screening Platform for Early Antibody Functionality Testing". Hamburg & Basel....
-  4-Antibody AG. (9/19/11). "Press Release: 4-Antibody AG Meets Next Milestone in Boehringer Ingelheim Collaboration". Basel....
To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to firstname.lastname@example.org and simply fill the subject line with the word »LSG newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)